These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 12213537

  • 1. Nicotinamide therapy protects against both necrosis and apoptosis in a stroke model.
    Yang J, Klaidman LK, Chang ML, Kem S, Sugawara T, Chan P, Adams JD.
    Pharmacol Biochem Behav; 2002 Nov; 73(4):901-10. PubMed ID: 12213537
    [Abstract] [Full Text] [Related]

  • 2. Delayed treatment with nicotinamide (Vitamin B(3)) improves neurological outcome and reduces infarct volume after transient focal cerebral ischemia in Wistar rats.
    Mokudai T, Ayoub IA, Sakakibara Y, Lee EJ, Ogilvy CS, Maynard KI.
    Stroke; 2000 Jul; 31(7):1679-85. PubMed ID: 10884473
    [Abstract] [Full Text] [Related]

  • 3. The effects of nicotinamide on energy metabolism following transient focal cerebral ischemia in Wistar rats.
    Yang J, Klaidman LK, Nalbandian A, Oliver J, Chang ML, Chan PH, Adams JD.
    Neurosci Lett; 2002 Nov 22; 333(2):91-4. PubMed ID: 12419488
    [Abstract] [Full Text] [Related]

  • 4. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
    Abdelkarim GE, Gertz K, Harms C, Katchanov J, Dirnagl U, Szabó C, Endres M.
    Int J Mol Med; 2001 Mar 22; 7(3):255-60. PubMed ID: 11179503
    [Abstract] [Full Text] [Related]

  • 5. Nicotinamide reduces infarction up to two hours after the onset of permanent focal cerebral ischemia in Wistar rats.
    Ayoub IA, Lee EJ, Ogilvy CS, Beal MF, Maynard KI.
    Neurosci Lett; 1999 Jan 04; 259(1):21-4. PubMed ID: 10027546
    [Abstract] [Full Text] [Related]

  • 6. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
    Iwashita A, Tojo N, Matsuura S, Yamazaki S, Kamijo K, Ishida J, Yamamoto H, Hattori K, Matsuoka N, Mutoh S.
    J Pharmacol Exp Ther; 2004 Aug 04; 310(2):425-36. PubMed ID: 15075382
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ, Bourgeois M, Harbison RD.
    Cardiovasc Toxicol; 2018 Dec 04; 18(6):493-506. PubMed ID: 29968072
    [Abstract] [Full Text] [Related]

  • 13. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.
    Culman J, Nguyen-Ngoc M, Glatz T, Gohlke P, Herdegen T, Zhao Y.
    Exp Neurol; 2012 Dec 04; 238(2):243-53. PubMed ID: 22995601
    [Abstract] [Full Text] [Related]

  • 14. Neuroprotective effect of combination of poly (ADP-ribose) polymerase inhibitor and antioxidant in middle cerebral artery occlusion induced focal ischemia in rats.
    Gupta S, Kaul CL, Sharma SS.
    Neurol Res; 2004 Jan 04; 26(1):103-7. PubMed ID: 14977067
    [Abstract] [Full Text] [Related]

  • 15. Nicotinamide attenuates retinal ischemia and light insults to neurones.
    Ji D, Li GY, Osborne NN.
    Neurochem Int; 2008 Jan 04; 52(4-5):786-98. PubMed ID: 17976861
    [Abstract] [Full Text] [Related]

  • 16. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
    Endres M, Wang ZQ, Namura S, Waeber C, Moskowitz MA.
    J Cereb Blood Flow Metab; 1997 Nov 04; 17(11):1143-51. PubMed ID: 9390645
    [Abstract] [Full Text] [Related]

  • 17. Nicotinamide as a precursor for NAD+ prevents apoptosis in the mouse brain induced by tertiary-butylhydroperoxide.
    Klaidman LK, Mukherjee SK, Hutchin TP, Adams JD.
    Neurosci Lett; 1996 Mar 08; 206(1):5-8. PubMed ID: 8848280
    [Abstract] [Full Text] [Related]

  • 18. Combinatorial-approached neuroprotection using pan-caspase inhibitor and poly (ADP-ribose) polymerase (PARP) inhibitor following experimental stroke in rats; is there additional benefit?
    Yap E, Tan WL, Ng I, Ng YK.
    Brain Res; 2008 Feb 21; 1195():130-8. PubMed ID: 18207135
    [Abstract] [Full Text] [Related]

  • 19. Neuroprotective effects of poly (ADP-ribose) polymerase inhibitors in transient focal cerebral ischemia of rats.
    Sun AY, Cheng JS.
    Zhongguo Yao Li Xue Bao; 1998 Mar 21; 19(2):104-8. PubMed ID: 10374629
    [Abstract] [Full Text] [Related]

  • 20. Long-term neuroprotective effect of inhibiting poly(ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment.
    Ding Y, Zhou Y, Lai Q, Li J, Gordon V, Diaz FG.
    Brain Res; 2001 Oct 12; 915(2):210-7. PubMed ID: 11595210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.